THU-366 - The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver disease
Autor: | Boursier, J., Vergniol, J., Lannes, A., Hiriart, J.-B., Oberti, F., Le Bail, B., Michalak, S., Chermak, F., Bertrais, S., Foucher, J., Fouchard-Hubert, I., Charbonnier, M., Rousselet, M.-C., Cales, P., de Ledinghen, V. |
---|---|
Zdroj: | In Journal of Hepatology 2017 66(1) Supplement:S161-S162 |
Databáze: | ScienceDirect |
Externí odkaz: |